Previous close | 100.53 |
Open | 100.53 |
Bid | 87.00 |
Ask | 91.05 |
Strike | 90.00 |
Expiry date | 2023-03-17 |
Day's range | 100.53 - 100.53 |
Contract range | N/A |
Volume | |
Open interest | 40 |
Pfizer/BioNTech, Moderna and Novavax are included in this Analyst Blog.
Teladoc Health (NYSE: TDOC) sank 74% last year -- and for one particular reason. The telemedicine giant reported two billion-dollar noncash goodwill impairment charges. Both were linked to the acquisition of chronic-care specialist Livongo.
Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.